Recommended Topic Related To:

Duavee

"The U.S. Food and Drug Administration today approved Brisdelle (paroxetine)to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mes"...

Duavee

OVERDOSE

In case of overdosage, there is no specific antidote, and the treatment should be symptomatic.

Symptoms of overdosage of estrogen-containing products in adults and children may include nausea, vomiting, breast tenderness, dizziness, abdominal pain, drowsiness/fatigue; withdrawal bleeding may occur.

CONTRAINDICATIONS

DUAVEE is contraindicated in women with any of the following conditions:

  • Undiagnosed abnormal uterine bleeding
  • Known, suspected, or past history of breast cancer
  • Known or suspected estrogen-dependent neoplasia
  • Active deep venous thrombosis, pulmonary embolism, or history of these conditions
  • Active arterial thromboembolic disease (for example, stroke, myocardial infarction) or history of these conditions
  • Hypersensitivity (for example, anaphylaxis, angioedema) to estrogens, bazedoxifene, or any ingredients
  • Known hepatic impairment or disease
  • Known protein C, protein S, or antithrombin deficiency or other known thrombophilic disorders
  • Pregnancy, women who may become pregnant, and nursing mothers. DUAVEE may cause fetal harm when administered to a pregnant woman. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus

Last reviewed on RxList: 11/7/2013
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.